Kawasaki disease is the most common cause of multisystem vasculitis in childhood. The
resultant coronary artery lesions make Kawasaki disease the leading cause of acquired heart …

Objective. To evaluate the use and efficacy of belimumab in academic practices. Belimumab
is a human monoclonal antibody that inhibits soluble B lymphocyte stimulator and has been …

Systemic lupus erythematosus (SLE) is a chronic, multisystem, autoimmune disease of
unknown etiology, whose hallmark is the production of autoantibodies. B cells are promising …

Belimumab (Benlysta ® ) is a fully humanized monoclonal antibody that inhibits B lymphocyte
stimulator (BLyS, also known as B cell-activating factor of the tumor necrosis factor family) …

Aim To assess safety of COVID‐19 vaccination in paediatric patients with immune‐mediated
inflammatory disease (IMID). Methods Subjects of 5–21 years of age with IMID who …

Objective Different classification criteria for systemic lupus erythematosus (SLE) have been
proposed for many years. The most widely used and accepted criteria has been the 1997 …

Belimumab (Benlysta ® ) is a fully humanized monoclonal antibody that inhibits B-lymphocyte
stimulator (also known as B cell activating factor of the tumor necrosis factor family) and …

Objectives Immunosuppressed paediatric patients with rheumatic disease (RD) may be at
risk for severe or critical disease related to severe acute respiratory syndrome coronavirus 2 (…

Background Systemic lupus erythematosus (SLE) is a multi-system, complex disease in
which the environment interacts with inherited genes to produce broad phenotypes with inter-…

Background/Objectives Mycophenolate mofetil (MMF) is used to treat pediatric-onset lupus
nephritis (pLN). Data are equivocal on the use of plasma mycophenolic acid (MPA) levels as …